focus -WSS

focus

author：explore 2025-09-29 21:12:42 - browse：318

LONDON — AstraZeneca said Friday an experimental drug tamped down the progression of a certain type of breast cancer in a Phase 3 trial, a win for the company after the same drug produced underwhelming results in a lung cancer trial over the summer.

The drug, called datopotamab deruxtecan or Dato-DXd for short, succeeded on one of its primary endpoints of improving progression-free survival compared to chemotherapy in certain breast cancer patients who had previously been treated with other therapies.

AstraZeneca, which is developing Dato-DXd with partner Daiichi Sankyo, said that the data for the other primary endpoint of overall survival were not “mature” as of this interim analysis, but that there was a positive trend. The trial is continuing.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Here’s what’s in the FDA plan to include pregnant women in clinical trials

hotspot

WSS

Abbott's new heart device gets FDA advisory panel nod

Why the Crimean Bridge is key to Russia's war in Ukraine

Juul documents reveal insider tactics on political lobbying

Too many hospitalized Covid

Why the Crimean Bridge is key to Russia's war in Ukraine

Congress considering partial increase for doctor pay in Medicare

explore

focus

entertainment

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Stanford updates investigation of president’s past research

Apple is now the first public company to be valued at $3 trillion

Latigo launches with $135 million for Vertex

Apple is now the first public company to be valued at $3 trillion

Why Eli Lilly’s earnings didn’t quite live up to the hype

In age of alternative facts, a scholarly course on calling out crap

Plane’s emergency slide plummets from sky, hits Chicago home

ChatGPT in medicine: STAT answers readers' burning questions

Having children helps parents live longer, especially after age 80

hotspot

'Reaching a detente': STAT's Helen Branswell on covering Covid

Latigo launches with $135 million for Vertex

Medical experts are missing from AI regulatory conversations

Celebrate National Dole Whip Day for 3 days this week at Disney

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

TikTok cracks down on users posting about weight loss drugs

focus

focus

hotspot

hotspot